MedPath

Pressure and Diabetic Foot

Not Applicable
Recruiting
Conditions
Diabetes and Risk of Diabetic Foot Ulcer
Interventions
Other: Measure of cutaneous microcirculation
Registration Number
NCT03213093
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Diabetic foot ulcer (DFU) is a worldwide burden in the management of patients with diabetes. Peripheral neuropathy has a key role in the physiopathology of DFU. Others factors as skin vulnerability to plantar pressure, glycation of skin protein, articular rigidity, vascular component and abnormal foot plantar pressure are also important to take into account. The aim of the study is to assess prospectively different factors involved in DFU pathogenesis notably the neurovascular response to non noxious pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Age >18 years
  • Type 2 diabetic subject
  • Absence of active diabetic foot ulcer
  • Patients "Grade 0", "Grade 1", "Grade 2" or "Grade 3" of the International Working Group on Diabetic Foot Risk Classification defined by:
  • absence of alteration of perception of Monofilament 10g at the level of the plantar arch for the "grade 0"
  • alteration of perception of Monofilament 10g at the level of the plantar arch for the "grade 1"
  • alteration of perception of Monofilament 10g at the level of the plantar arch associated with foot deformity and / or an arteriopathy defined by the absence of perception of one of the two peripheral pulses for the "grade 2"
  • History of diabetic foot ulcer for the "grade 3"
  • Signature of consent to participate in the study
Read More
Exclusion Criteria
  • Chronic alcoholism with usual consumption of at least 5 alcoholic drinks per day
  • Pregnancy
  • Congenital methemoglobinemia.
  • Porphyria
  • Skin injured on the tibia, whatever the lesion
  • Recent major cardiovascular history (less than 3 months)
  • Severe renal disease (serum creatinine> 300 μmol.l-1)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diabetic patients with a risk of diabetic foot ulcerMeasure of cutaneous microcirculation-
Primary Outcome Measures
NameTimeMethod
the rate of incidence of diabetic foot ulcerAt any time during a 3 years follow-up

A diabetic foot ulcer is defined as a breakdown in the skin under malleolus

Secondary Outcome Measures
NameTimeMethod
Neurovascular response to pressureAt the end of the 3-year follow-up

Receiver Operating Characteristic (ROC) analysis for neurovascular response to predict foot ulcer. Results are expressed in arbitrary unit.

Trial Locations

Locations (1)

service d'endocrinologie, Centre Hospitalier Lyon Sud

🇫🇷

Pierre-Bénite, France

© Copyright 2025. All Rights Reserved by MedPath